Systems | Development | Analytics | API | Testing

Today, we are excited to announce the public preview of search indexes and related SQL SEARCH functions in BigQuery. This is a new capability in BigQuery that allows you to use standard BigQuery SQL to easily find unique data elements buried in unstructured text and semi-structured JSON, without having to know the table schemas in advance. By making row lookups in BigQuery efficient, you now have a powerful columnar store and text search in a single data platform.

As an ISV company selling a SaaS application, you have built analytics into your software because you know customers highly value insights into the data that's held within your application. Giving your customers business intelligence (BI) and analytics within your application offers them a window of insight into the data to help them optimize their business. You deliver more value which boosts end user adoption and means your client buys for longer.

In this series of demystifying the tech trends, my colleagues and I will be looking at busting the buzzwords to help you keep on track. Concerned about puzzling parlance, analytics argot, techie terminology – or plain old jargon? This series breaks down words and concepts to give you the deepest insight and understanding into how to talk the talk in the world of tech, so you can engage in conversations with the confidence of being data literate.

Greek philosopher Heraclitus wasn’t talking about the challenge of today’s enterprise IT landscape but the quote certainly fits. From the advent of the first digital computer in the 1940s to the emergence of first public cloud in 2004, the rate of change has only accelerated. In fact, over 60% of corporate data resides in the cloud in 2022, up from 50% last year.

Vaccine development became the top priority for the life sciences industry – delivering new vaccines at unprecedented speed and maneuvering large-scale production processes. Numerous factors helped accelerate the vaccine roll-out including prior research, genome sequencing, jumping the FDA approval queue and a plethora of testing volunteers. So now that we’ve experienced these advancements, how can the industry keep momentum to speed-up innovative solutions across healthcare?

A global leader in pharmaceuticals found themselves faced with a unique spin on a common challenge: Their biopharmaceutical division — responsible for producing vaccines and generating over $1 billion in annual sales — was struggling to turn raw data into trusted insights. Data underlies everything the global pharmaceutical company does, however, without data they can trust, they would be at risk of taking longer to get vaccines to market and incurring higher expenses along the way.